In vivo pharmacokinetic parameters in lungs for bicyclic 4-nitroimidazole analogs.

Figshare2015-12-02 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/_In_vivo_pharmacokinetic_parameters_in_lungs_for_bicyclic_4_nitroimidazole_analogs_/1147268 数据链接链接失效反馈

官方服务：

资源简介：

In vivo pharmacokinetic parameters in lungs for bicyclic 4-nitroimidazole analogs.

创建时间：

2015-12-02

The impact of menstrual cycle on the pharmacokinetics of antiseizure medications and lithium: a systematic review and meta-analysis

吸入药物药代动力学

女性生理

Our aim was to quantify the impact of menstrual cycle phases on the pharmacokinetics of antiseizure medications (ASM) and lithium. A systematic literature search was conducted in PubMed/EMBASE in Marc

DataCite Commons2025-04-01 更新80

Pharmacokinetic Evaluation of Amphotericin B in Lung Tissue: Lung Lymph Distribution after Intravenous Injection and Airspace Distribution after Aerosolization and Inhalation of Amphotericin B

吸入药物药代动力学

抗真菌药物

We have studied the pharmacokinetics of amphotericin B (AmB) in lung lymph circulation and bronchial-wash fluid after intravenous infusion and inhalation, respectively. For two experiments with awake

PubMed Central10

Dataset from A Randomized Double-blind, Placebo-controlled, Crossover, Dose Escalation Study to Examine the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Single Inhaled Doses of GSK704838 and Tiotropium Bromide

COPD药物临床试验

吸入药物药代动力学

GSK704838C is a potent, pan-active mAChR antagonist, which is being developed for once-daily treatment of chronic obstructive pulmonary disease (COPD).

NIAID Data Ecosystem00

Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial

吸入药物药代动力学

COPD药物临床试验

Inhaled umeclidinium (UMEC) and the combination of inhaled UMEC with vilanterol (UMEC/VI) are approved maintenance treatments for chronic obstructive pulmonary disease in the US and EU. This was a ran

NIAID Data Ecosystem30

Dataset from A Single-centre, Double-blind (Sponsor Open), Placebo Controlled Two Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2292767 as a Dry Powder in Healthy Participants Who Smoke Cigarettes

吸入药物药代动力学

早期临床试验

This study is the first administration of GSK2292767 to humans. The study will evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single and repeat inhaled doses of

NIAID Data Ecosystem00

In vivo pharmacokinetic parameters in lungs for bicyclic 4-nitroimidazole analogs.

资源简介：

相关数据集